Patients are all set to gain from the reduced waiting times as the UK government looks to give people more options on where they receive their care with the updates coming to the NHS app. These changes mean that after having a word with their general practitioner, patients will be able to compare their wait times, care quality, as well as the distance between up to five healthcare providers.

As per a recent data, 21% of the NHS providers in the UK have completely eliminated 18-month waits.

A patient association study conducted in sync with the independent sector in 2022 showed that people were only required to travel an average of 13.2 miles to go to the best service provider from the worst, and all of this made sure to save a waiting time of 14 weeks on average.

It is well worth noting that new software as well as IT updates will also go on to make it very easy for the general practitioners to refer patients for treatment, with training set to be rolled out so as to make sure that the staff makes the most out of technology.

Apparently, an awareness campaign is also set to be launched, letting patients utilise their right to make a choice, with numbers suggesting that only 1 in 10 are doing that currently.

According to Rachel Power, the chief executive of the Patients Association, in early 2023, the survey on patients’ experiences of healthcare went on to find out that only one in six patients that they had questioned were given the opportunity to choose where they would have their hospital care.

She added that they hope that the planned communications campaign will go on to clearly explain the choice and also encourage people to administer it. Those who do not have access to the required technology can either opt for a different provider with the help of their general practitioner or call the National Referral Helpline. Importantly, travel costs that are reasonable will be refundable with the government, with the NHS keen on making sure that travel doesn’t remain a roadblock.

Amanda Pritchard, the chief executive of NHS England, says that by offering patients a greater choice as well as more information about their care by way of the convenience of the NHS app, they can change the way patients go on to access treatment options while at the same time building on the incredible work that has already been done by the NHS staff all around the country when it comes to bringing down the longest waits that have been observed for care.

Dr. Tedros Adhanom Ghebreyesus, the WHO chief, has gone on to warn that the world must make sure to prepare itself for a future virus that can be even deadlier than COVID-19. He spoke on this at the annual health assembly that took place in Geneva and put stress on the fact that one needs to prioritise negotiations that are targeted at preventing the world from the future pandemics.

As per the WHO chief, the world must ensure to prepare for a virus that’s deadlier than COVID, to which apparently a minimum of 20 million people succumbed. Threat related to another variant coming-up that leads to a surge in the disease as well as deaths remains, and there is also a possibility of another pathogen coming up that has even more deadly potential.

One of the reports from a daily stated that the WHO has gone on to identify nine priority diseases that happen to pose the biggest risk when it comes to public health. These diseases can be termed risky because of a lack of treatment options or their ability to cause a pandemic.

Dr. Tedros said that the world was indeed taken by surprise and was found completely unprepared for COVID-19, which is regarded as the most severe health crisis of the century.

Speaking at the assembly, weeks after eliminating the tag of global emergency status for COVID-19, the WHO chief said that it is indeed time to advance the negotiations when it comes to preventing the world from the next pandemic.

He added that it is not a wise step to kick this down the road, as the next pandemic is bound to come knocking. If the changes aren’t made by the authorities, then who will? he remarked. Tedros added that if the changes are not made now, then when?

The 10-day yearly World Health Assembly held in Geneva goes on to coincide with the 75^th anniversary of WHO and is set to take into account issues pertaining to health challenges worldwide such as future pandemics, polio eradication, and also aiding to ease the health emergency in Ukraine that’s been triggered due to the Russian war.

Avance Clinical the leading award-winning Australian and North American CRO that offers the programs ClinicReady and GlobalReady for early phase biotech companies to speed up the path to regulatory approval, has been invited to join the Global Health Summit campaign which will be featured on Reuters.

Avance Clinical CEO, Yvonne Lungershausen, Chief Scientific Officer Gabriel Kremmidiotis, and Head of Scientific and Regulatory Affairs Jorgen Mould are interviewed in a new Global Health video featured on Reuters news service about the importance of quality clinical trials as part of the drug development process.

The campaign is a collection of interviews and video documentaries, highlighting international business leaders and healthcare specialists from various industries. The series will showcase organisations spearheading specific health initiatives, developing ground-breaking medicine and complex health technologies, and taking on the challenges of both physical and mental health globally.

The Global Health program launches at the upcoming Global Health Summit on 25-27 May 2023 at the prestigious Intercontinental Hotel in Geneva, bringing together 100 leaders and executives from various sectors of the Private and Public Healthcare Industry.

The event will feature round table discussions where participants will discuss strategies, share knowledge and expertise, and identify opportunities for collaboration. This will be complemented by keynote speeches and panel discussions that will explore the latest trends and emerging issues in the healthcare industry.

Avance Clinical CEO, Yvonne Lungershausen and Executive VP North American Operations John Mann will be attending the Global Health Summit and Yvonne will be a leading panelist. Avance Clinical is at the cutting edge of clinical trial technology and has recently been ranked as the world leader in DCT technology adoption by GlobalData and Clinical Trial Arena in the CRO sector.

The report found 46% of Avance Clinical’s trials incorporated some elements of DCT technologies in 2022 including telemedicine, remote monitoring, and digital data collection. The DCT report also noted that Avance Clinical’s staff training in the latest technologies was a key factor in the ranking.

Avance Clinical’s unique clinical offering GlobalReady enables biotechs that have completed early to mid-phases in Australia to rapidly and seamlessly transition to the US in preparation for FDA approvals, all with the one CRO and dedicated teams across both regions, which reduces time and cost and delivers quality data.

There are currently more than 280 Phase III global trials that have conducted their Phase I study in Australia, which demonstrates Australian data acceptability with the FDA and other major regulatory authorities.

More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program.

This seamless GlobalReady journey is designed so biotechs can:

– Take advantage of the Australian early-phase clinical trial landscape (No IND and 43.5% tax rebate)

– Transition or expand into North America for later phases – without changing CROs (retain study knowledge and processes/team)

– Seamlessly operationalize global dose-escalation and dose-expansion trials across the two regions

– Harness significant speed and cost advantages

– Be assured of quality data – transferable and readily acceptable by the FDA and other regulatory authorities

Pathology plays a crucial role in diagnosing and managing diseases, making it essential to ensure efficient scaling of pathology resources. Recent advancements in technology make satisfying the increasing demand for accurate and timely diagnoses possible by implementing some key strategic approaches.

If healthcare providers are going to maintain their ability to perform pathological services at scale, they will have to leverage these advances in tech and look for outsourcing opportunities. There are three key strategies for efficiently scaling up your pathology resources to meet growing needs while continuing to deliver quality patient care.

Developing Partnerships With External Pathology Laboratories

Collaborating with outside pathology labs and outsourcing pathology tasks to them is key to efficiently scaling up your pathology resources. By forging partnerships, healthcare organizations can leverage the expertise and capacity of external labs to augment their own capabilities and respond to surges in demand. Source BioScience provides technically advanced cellular and digital pathology services for a wide range of clients, helping them to achieve timescale targets while maintaining the highest quality reporting and service standards.

Working with laboratory service partners like SourceBioScience enables the sharing of resources, skillsets, and best practices. It also allows for workload balancing, can help to ensure timely diagnoses, and reduces timescale bottlenecks to get results to where they need to be quicker. Establishing a network of trusted external labs can significantly enhance pathology service scalability and flexibility.

Leveraging Cloud Computing For Data Management

With the exponential growth of digital pathology data, managing and storing large volumes of images and associated documentation can be overwhelming for human and IT resources. Cloud computing provides a scalable and cost-effective solution for efficient data management in pathology departments. Storing data in the cloud means healthcare organizations can overcome the limitations and the costs of onsite storage capacity while maintaining accessibility with reliable data backups.

Cloud-based pathology platforms allow pathologists to securely store, retrieve, and share digital images and patient information from anywhere, at any time. The cloud also makes collaboration easier, enabling remote consultations and knowledge-sharing among pathologists, regardless of where they are. Advanced data analytics and machine learning capabilities can also be applied to cloud-stored pathology data, unlocking valuable insights for research and personalized medicine in the future.

Utilizing Telepathology For Remote Diagnostics

Telepathology, the practice of diagnosing pathology specimens remotely, offers tremendous potential for efficiently scaling up pathology resources, especially in remote and rural areas that often go underserved. Through telepathology, pathologists can access and evaluate digital images of slides remotely, eliminating the need for physical specimen transportation and greatly reducing turnaround times.

Telepathology enables quick consultations between pathologists, facilitating second opinions and subspecialty expertise, regardless of geographical location. It also allows for remote training and mentoring, enabling skill development and knowledge transfer. The use of telepathology systems combined with secure communication to ensure patient data privacy maintains compliance with regulatory standards.

Efficiently scaling up pathology resources is crucial to meet the increasing demand for accurate and timely diagnoses. Making smarter use of technological advancements and external resources is the most cost-efficient way to continue providing the best quality care at the largest possible scale. Look for ways to implement these strategies in your healthcare organization.

5C Network, a leading digital diagnostic delivery platform, today has announced the launch of Prodigi PASS, an innovative platform that is set to transform access to healthcare diagnostics services across India. Prodigi PASS empowers patients with unparalleled convenience and price discovery within their local vicinity by providing a network of high-quality diagnostic centers.

Prodigi PASS is a first-of-its-kind diagnostic fulfillment service that empowers patients to conveniently schedule their diagnostic appointments online through their preferred aggregation platforms. With an astounding 90% of patients undergoing diagnostic scans without prior appointments, the selection process for diagnostic centers rarely prioritizes quality resulting in subpar experiences. Prodigi PASS empowers patients by enabling them to conveniently schedule their visits to diagnostic centers through online aggregator platforms like Tata 1mg by eliminating delays and ensuring prompt execution of diagnostic scans without compromising on quality.

By reshaping the patient experience, Prodigi PASS streamlines the entire process, offering a seamless and efficient journey for individuals seeking reliable diagnostic delivery solutions. Patients gain financial transparency as they discover the process for different diagnostic services, allowing them to make informed decisions. Moreover, Prodigi PASS allows patients with all major insurance plans to access necessary diagnostic services easily.

Initially introduced in Bengaluru with over 50 diagnostic centers across the city, the service is soon to be expanded to other major cities including Mumbai, Hyderabad, Chennai, Delhi, Ahmedabad, Pune, . 5C Network aims to connect over 500 diagnostic centers and hospitals nationwide with patient aggregator platforms in the next three months, with TATA 1mg and Even serving as the primary aggregation partners for this service.

Prodigi PASS is poised to revolutionize the way individuals choose diagnostic centers, prioritizing patient satisfaction and convenience. By offering a seamless patient experience and facilitating access to high-quality diagnostic services, 5C Network aims to become the go-to platform for individuals seeking reliable diagnostic delivery solutions.

In addition to its exceptional user experience, Prodigi PASS provides financial transparency allowing patients to discover prices for different diagnostic services, empowering them to make informed decisions. Furthermore, Prodigi PASS allows patients with all major insurance plans to access necessary diagnostic services easily.

Prodigi PASS is not only beneficial for patients but also for hospitals lacking essential diagnostic equipment. Healthcare facilities can conveniently schedule appointments ensuring a seamless and efficient patient experience. Clinicians can effortlessly refer patients for necessary through Prodigi PASS and receive reports on their mobile devices facilitating comprehensive care delivery within the healthcare ecosystem.

This launch follows 5C Network’s recent acquisition of Krayen, a U.S.-based health-tech startup that is further strengthening their capabilities in the digital diagnostics space. With a network of 400 radiologists and generating 2 million reports annually, 5C Network is at the forefront of revolutionizing healthcare infrastructure in India.

Kalyan Sivasailam, CEO of 5C Network, stated, “Prodigi PASS addresses a critical issue in India, where less than 20% of hospitals have CT/MRI machines, leaving a significant gap. Diagnostic centers, which contribute to two-thirds of cross-section investments, play a vital role in closing this disparity. To tackle this challenge, Prodigi PASS actively fosters a collaborative network among diagnostic establishments. By linking these centers with patients, the platform simplifies the identification of the most suitable diagnostic facility and ensures prompt completion of scans, ultimately enhancing overall efficiency and improving the patient experience.”

Plastic surgery has evolved over the years, with present use in reconstructive and cosmetic areas. Therefore, patients often choose plastic surgery to correct injuries or conditions that affect their quality of life or enhance their physical appearance. For instance, reconstructive surgery can repair injuries from accidents or deformities from birth, while cosmetic surgery can improve one’s facial features or body contours. As social media becomes increasingly prevalent, experts recognize a growing emphasis on physical appearance in modern society, positioning cosmetic procedures as a solution to make someone more comfortable in their skin. Given the life-changing impact of each procedure, many agree that this decision is more than the surgery itself but the person behind it.

Dr. Ryan Neinstein is an example of a plastic surgeon who has made a significant impact in his field. In addition to his technical skills and expertise, Dr. Neinstein is committed to providing personalized care and attention to his patients, ensuring they receive the best possible outcome. He has also dedicated his time and resources to various philanthropic efforts, including his clinic’s Look Good, Feel Good, Do Good program. Through his contributions, Dr. Neinstein has not only improved the lives of his patients but also impacted the lives of those in his community who are less fortunate.

The Doctor Who is Inspiring Change

Dr. Neinstein founded Neinstein Plastic Surgery, a clinic specializing in minimally invasive body contouring and liposuction procedures. With his exceptional skill and attention to detail, he has revolutionized the standard by which other doctors conduct this procedure, making Liposuction and the surrounding Mommy Makeover faster, simpler, and less invasive. Patients who visit Neinstein Plastic Surgery also pride the clinic on its attention to personalized treatments tailored to their unique needs and goals, resulting in more natural outcomes.

By focusing on the patient’s natural contours and subtly enhancing them, Dr. Neinstein can provide a result that looks natural and proportional to the patient’s body. With natural-looking results, most mothers agree that they feel like themselves again. Moreover, mothers often opt for more natural-looking results since they are more sustainable as they age gracefully and maintain a consistent appearance.

Giving Mothers a Fresh Start With Plastic Surgery

When it comes to childbirth, women’s bodies can undergo significant physical changes that can be difficult to reverse. For Jen from Denver, Colorado, having seven children left her feeling embarrassed about her physical appearance. Like many mothers, she experienced cosmetic damages such as loose skin, sagging breasts, core muscle separation, and stubborn fat deposits. However, a mommy makeover from Dr. Ryan Neinstein of Neinstein Plastic Surgery changed her life in ways she never thought possible.

Dr. Neinstein’s unique take on the Mommy Makeover procedure caters to women who want to restore their pre-baby bodies. His mommy makeovers are tailored to each client’s needs, ensuring the best possible results. According to Dr. Neinstein, diet and exercise can only go so far when discussing the deflation of nipples and breasts and resistant fatty deposits. These changes can affect their self-esteem, confidence, and overall well-being. The medical community often agrees that this is where mommy makeovers come in.

The mommy makeover is a personalized treatment plan designed to address the physical changes during and after pregnancy. Although the specifics may vary, the procedure typically includes a combination of Liposuction, breast augmentation, tummy tuck and body contouring to restore a woman’s pre-baby body. In practice, a breast augmentation can restore volume and shape to breasts that have lost their fullness and firmness, while a tummy tuck can tighten a mother’s ab muscles and remove excess skin and fat from the stomach area.

Beyond the Operating Room

Beyond the operating room, many communities also note Dr. Neinstein’s clinic through his charitable deeds. His clinic’s “Look Good, Feel Good, Do Good” program encourages plastic surgeons to partner with local organizations to positively impact those in need. Dr. Neinstein’s team has partnered with various charities, including The Archer’s Project, SoulCycle, Release Recovery Foundation, and Animal Haven, to name a few. Through these partnerships, they have participated in toy drives, charity rides, and other initiatives that have helped underprivileged children, those struggling with substance abuse and mental health issues, and abandoned pets find new homes.

Dr. Neinstein’s philanthropic efforts demonstrate that making a difference in the world is not just about technical skills and experience. It’s also about having the desire to help others and the willingness to give back to the community. Through his actions, he has shown that plastic surgeons can play an active role in improving people’s lives outside the operating room and inspire clinics to do the same.

Carrying the Industry Forward

In addition to his charitable deeds, Dr. Neinstein has made significant contributions to plastic surgery through his innovations. His clinic’s dedication to providing personalized treatments has set a new standard for plastic surgery practices across the globe. In particular, his work in mommy makeovers and Lipo360 procedures has helped countless patients achieve their desired body shape and regain their confidence. By understanding each patient’s unique needs and goals, Dr. Neinstein’s patients have become living examples of how tailoring a cosmetic procedure to individual needs can improve the appearance and recovery process.

Anyone Can Make a Difference

Dr. Neinstein’s approach to plastic surgery is a testament to how factors like education, training, innovation, and philanthropy can allow any surgeon to make a difference in the world. Whether it be through creating new solutions and safer alternatives to the medical field, allowing each patient to gain their life back, or simply volunteering time and monetary resources to the community, plastic surgeons have many opportunities to make a real difference in the world.

Stereotaxis, the global leader in robotic technologies for the treatment of cardiac arrhythmias, announced the first treatment of patients with a newly launched Genesis Robotic Magnetic Navigation (RMN) system at Advocate Christ Medical Center in Chicago, Illinois.

Advocate Christ Medical Center, a part of Advocate Health, is the leading provider of robotic heart rhythm care in the Midwest. Electrophysiologists at the hospital have treated over 2,000 patients using advanced robotic technology. The hospital is now among the first in the world, and the first in Chicago, to offer the Genesis RMN system to patients.

“At Advocate Christ, we take pride in providing the highest quality care,” said Dr. Jeffrey Neiger, Cardiac Electrophysiologist at Advocate Christ Medical Center. “For more than a decade, our electrophysiology team has leveraged the precision and safety of robotics when treating our cardiac patients. With the adoption of Genesis, we are extending our commitment to that technological and clinical leadership.

Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

“We are excited to continue our partnership with Advocate Christ in advancing the frontiers of patient care and clinical science in cardiology,” said David Fischel, Chairman and CEO of Stereotaxis. “We look forward to working with them in ensuring the best possible heart care is available to the Chicago community.”